Vor Biopharma, Inc. VOR 深 滬
已收盤 09-20 16:00:00 美东时间
0.90
-0.042
-4.47%
華盛通- 最 高0.965
- 今 開0.96
- 成交量 44.00万股
- 最 低 0.89
- 昨 收 0.9421
- 總市值 6102.51万
- 52周最高 3.1399
- 市盈率 靜 --
- 換手率 0.65%
- 52周最低 0.70
- 委 比 73.33%
- 總股本 6780.57万
- 歷史最高 63.62
- 量 比 1.12
- 振 幅 7.96%
- 歷史最低 0.70
- 每 手 1
- 風險率 0.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of Oracle Corporation (NYSE:ORCL) rose sharply in today's pre-market tra...
09-10 18:41
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.
09-06 21:35
Vor Bio stock rallies post-market on trem-cel study data
Vor Bio (NASDAQ:VOR) stock rallied 64% in post-market trading Thursday after the company reported positive data for its gene-edited stem cell therapy trem-cel in the treatment of acute myeloid leukemi...
09-06 04:58
Vor Biopharma Advances Innovative Blood Cancer Therapies
Vor Biopharma ( ($VOR) ) has issued an update. Vor Biopharma Inc. has revealed ...
09-06 04:31
快讯 | Vor Biopharma，Inc.：巴克莱银行将目标价从10美元下调至3美元
Vor Biopharma, Inc. : Barclays Cuts Target Price to $3 From $10
08-14 18:41
Vor Biopharma (VOR) Receives a Buy from Barclays
Barclays analyst Carter Gould maintained a Buy rating on Vor Biopharma (VOR – R...
08-14 15:46
快讯 | Vor Biopharma第二季度的净利润为-27.8百万美元，低于IBES估计的-28.2百万美元。
Vor Biopharma Q2 Net Income USD -27.8 Million Vs. IBES Estimate USD -28.2 Milli...
08-09 04:05
Voyager Therapeutics appoints Nathan Jorgensen as CFO
Voyager Therapeutics (NASDAQ:VYGR) announces the appointment of Nathan Jorgensen as CFO, effective July 8, 2024. Jorgensen most recently served as CFO for Vor Biopharma Inc. (VOR). More on Voyager The...
06-13 19:22
Vor Biopharma Announces Interim Financial Leadership Changes
The latest update is out from Vor Biopharma (VOR). Vor Biopharma Inc. is experi...
06-11 05:19
